Pathios Therapeutics
Milton, United Kingdom · Founded 2017 · $33.8M raised
- Headquarters
- Milton
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- pathiostherapeutics.com
- Total Funding
- $33.8M
- Last Round
- $25.0M Series BApr 2024
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Pathios Therapeutics is a clinical-stage oncology and immunology company targeting GPR65 to restore immune response to cancer.
Summary
Pathios Therapeutics is a Biotech company based in Milton, United Kingdom, founded in 2017. It has raised $33.8M in total across 3 rounds, most recently a $25.0M Series B round in Apr 2024. Investors include Brandon Capital Partners, Canaan Partners and Innovate UK.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2024
Sign up to see all 3 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pathios-therapeutics"><img src="https://indexed.vc/api/badge/company/pathios-therapeutics" alt="Pathios Therapeutics on Indexed.vc" width="260" height="76" /></a>